377 related articles for article (PubMed ID: 25203891)
1. Hormone therapy and mood in perimenopausal and postmenopausal women: a narrative review.
Toffol E; Heikinheimo O; Partonen T
Menopause; 2015 May; 22(5):564-78. PubMed ID: 25203891
[TBL] [Abstract][Full Text] [Related]
2. Associations between psychological well-being, mental health, and hormone therapy in perimenopausal and postmenopausal women: results of two population-based studies.
Toffol E; Heikinheimo O; Partonen T
Menopause; 2013 Jun; 20(6):667-76. PubMed ID: 23277355
[TBL] [Abstract][Full Text] [Related]
3. Bioidentical Estrogen for Menopausal Depressive Symptoms: A Systematic Review and Meta-Analysis.
Whedon JM; KizhakkeVeettil A; Rugo NA; Kieffer KA
J Womens Health (Larchmt); 2017 Jan; 26(1):18-28. PubMed ID: 27603786
[TBL] [Abstract][Full Text] [Related]
4. Depression and the menopause: why antidepressants are not enough?
Graziottin A; Serafini A
Menopause Int; 2009 Jun; 15(2):76-81. PubMed ID: 19465674
[TBL] [Abstract][Full Text] [Related]
5. Guidelines for the Evaluation and Treatment of Perimenopausal Depression: Summary and Recommendations.
Maki PM; Kornstein SG; Joffe H; Bromberger JT; Freeman EW; Athappilly G; Bobo WV; Rubin LH; Koleva HK; Cohen LS; Soares CN
J Womens Health (Larchmt); 2019 Feb; 28(2):117-134. PubMed ID: 30182804
[TBL] [Abstract][Full Text] [Related]
6. Role of estrogen in the treatment of depression.
Grigoriadis S; Kennedy SH
Am J Ther; 2002; 9(6):503-9. PubMed ID: 12424508
[TBL] [Abstract][Full Text] [Related]
7. Guidelines for the evaluation and treatment of perimenopausal depression: summary and recommendations.
Maki PM; Kornstein SG; Joffe H; Bromberger JT; Freeman EW; Athappilly G; Bobo WV; Rubin LH; Koleva HK; Cohen LS; Soares CN;
Menopause; 2018 Oct; 25(10):1069-1085. PubMed ID: 30179986
[TBL] [Abstract][Full Text] [Related]
8. Physical, psychological, and menopause-related symptoms and minor psychiatric disorders in a community-based sample of Brazilian premenopausal, perimenopausal, and postmenopausal women.
Oppermann K; Fuchs SC; Donato G; Bastos CA; Spritzer PM
Menopause; 2012 Mar; 19(3):355-60. PubMed ID: 21971211
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of citalopram as a monotherapy or as an adjunctive treatment to estrogen therapy for perimenopausal and postmenopausal women with depression and vasomotor symptoms.
Soares CN; Poitras JR; Prouty J; Alexander AB; Shifren JL; Cohen LS
J Clin Psychiatry; 2003 Apr; 64(4):473-9. PubMed ID: 12716252
[TBL] [Abstract][Full Text] [Related]
10. The effects of compounded bioidentical transdermal hormone therapy on hemostatic, inflammatory, immune factors; cardiovascular biomarkers; quality-of-life measures; and health outcomes in perimenopausal and postmenopausal women.
Stephenson K; Neuenschwander PF; Kurdowska AK
Int J Pharm Compd; 2013; 17(1):74-85. PubMed ID: 23627249
[TBL] [Abstract][Full Text] [Related]
11. EFFICACY OF ESTRADIOL IN PERIMENOPAUSAL DEPRESSION: SO MUCH PROMISE AND SO FEW ANSWERS.
Rubinow DR; Johnson SL; Schmidt PJ; Girdler S; Gaynes B
Depress Anxiety; 2015 Aug; 32(8):539-49. PubMed ID: 26130315
[TBL] [Abstract][Full Text] [Related]
12. Progression of female reproductive stages associated with bipolar illness exacerbation.
Marsh WK; Ketter TA; Crawford SL; Johnson JV; Kroll-Desrosiers AR; Rothschild AJ
Bipolar Disord; 2012 Aug; 14(5):515-26. PubMed ID: 22650986
[TBL] [Abstract][Full Text] [Related]
13. Effect of reproductive hormones and selective estrogen receptor modulators on mood during menopause.
Soares CN; Poitras JR; Prouty J
Drugs Aging; 2003; 20(2):85-100. PubMed ID: 12534310
[TBL] [Abstract][Full Text] [Related]
14. [Mood disorders in perimenopausal women: hormone replacement or antidepressant therapy?].
Bertschy G; De Ziegler D; Bianchi-Demicheli F
Rev Med Suisse; 2005 Sep; 1(33):2155-6, 2159-61. PubMed ID: 16223218
[TBL] [Abstract][Full Text] [Related]
15. Neurophysiologic changes during estrogen augmentation in perimenopausal depression.
Morgan ML; Cook IA; Rapkin AJ; Leuchter AF
Maturitas; 2007 Jan; 56(1):54-60. PubMed ID: 16835012
[TBL] [Abstract][Full Text] [Related]
16. Management of depressive symptoms in peri- and postmenopausal women: EMAS position statement.
Stute P; Spyropoulou A; Karageorgiou V; Cano A; Bitzer J; Ceausu I; Chedraui P; Durmusoglu F; Erkkola R; Goulis DG; Lindén Hirschberg A; Kiesel L; Lopes P; Pines A; Rees M; van Trotsenburg M; Zervas I; Lambrinoudaki I
Maturitas; 2020 Jan; 131():91-101. PubMed ID: 31740049
[TBL] [Abstract][Full Text] [Related]
17. The 5HTT and MAO-A polymorphisms associate with depressive mood and climacteric symptoms in postmenopausal women.
Grochans E; Grzywacz A; Jurczak A; Samochowiec A; Karakiewicz B; Brodowska A; Starczewski A; Samochowiec J
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():125-30. PubMed ID: 23707423
[TBL] [Abstract][Full Text] [Related]
18. Melatonin in perimenopausal and postmenopausal women: associations with mood, sleep, climacteric symptoms, and quality of life.
Toffol E; Kalleinen N; Haukka J; Vakkuri O; Partonen T; Polo-Kantola P
Menopause; 2014 May; 21(5):493-500. PubMed ID: 24065140
[TBL] [Abstract][Full Text] [Related]
19. Mood, depression, and reproductive hormones in the menopausal transition.
Schmidt PJ
Am J Med; 2005 Dec; 118 Suppl 12B():54-8. PubMed ID: 16414327
[TBL] [Abstract][Full Text] [Related]
20. Short-term efficacy and safety of desvenlafaxine in a randomized, placebo-controlled study of perimenopausal and postmenopausal women with major depressive disorder.
Kornstein SG; Jiang Q; Reddy S; Musgnung JJ; Guico-Pabia CJ
J Clin Psychiatry; 2010 Aug; 71(8):1088-96. PubMed ID: 20797382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
